Suzhou Suncadia Biopharmaceuticals Co., Ltd. clinical trials

A subsidiary of Jiangsu HengRui Medicine Co., Ltd.

The registry lists 102 studies whose lead sponsor is Suzhou Suncadia Biopharmaceuticals Co., Ltd.. 71 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 7, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 102. List all 102 → · All Jiangsu HengRui Medicine Co., Ltd. studies →

• An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.Not yet recruitingNCT07863167Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid TumorsRecruitingNCT07676903Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular CarcinomaNot yet recruitingNCT07691762Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02)RecruitingNCT06618664Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability and PharmacokineticsNot yet recruitingNCT07830199Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT07751341Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian CancerRecruitingNCT06840002Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal CancerRecruitingNCT07676162Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast CancerRecruitingNCT07679360Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLCRecruitingNCT06844474Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate CancerRecruitingNCT07735377Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBCRecruitingNCT07726992Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian CancerNot yet recruitingNCT07779538Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT07393542Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid TumorsRecruitingNCT07229612Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell CarcinomRecruitingNCT07239596Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-3079 in B-cell Non-Hodgkin LymphomaRecruitingNCT07661537Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-5421 in Patients With Multiple MyelomaRecruitingNCT07652281Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBCRecruitingNCT07424287Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma CancerRecruitingNCT07059221Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung CancerNot yet recruitingNCT07704645Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)RecruitingNCT06879145Phase 2/3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular CarcinomaNot yet recruitingNCT07682272Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-4506 Injection in Patients With Malignant TumorsRecruitingNCT07068932Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung CancerRecruitingNCT07489716Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal CancerRecruitingNCT07454720Phase 2/3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid TumorsRecruitingNCT07298772Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT07478302Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-9539 in Patients With Multiple MyelomaRecruitingNCT06484777Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical CancerRecruitingNCT07418749Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract CancerRecruitingNCT07450976Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid TumorsRecruitingNCT07229638Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy SubjectsRecruitingNCT07414602Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid TumorsRecruitingNCT07028281Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric CancerRecruitingNCT05671822Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT07118527Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of SHR-7782 for Treatment of Advanced Malignant TumorsRecruitingNCT07123129Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)RecruitingNCT07229625Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid TumorRecruitingNCT07275242Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid TumorsRecruitingNCT06737731Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ CancerRecruitingNCT07110571Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid TumorsRecruitingNCT07028268Phase 2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast CancerRecruitingNCT07111832Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid TumorsRecruitingNCT06703177Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT07170995Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of SHR-3821 Injection in Subjects With Advanced Solid TumorsRecruitingNCT06618651Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial SpondyloarthritisRecruitingNCT06860750Phase 3

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical CancerRecruitingNCT06859775Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Trial of SHR-3792 Injection in Patients With Advanced Solid TumorsRecruitingNCT06907628Phase 1

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLCRecruitingNCT06754930Phase 1/2

  Sponsor listed in the registry: Suzhou Suncadia Biopharmaceuticals Co., Ltd.